Humana Inc. (HUM) Stock Price: $363.18+7.20 (+2.02%)
The total return cagr for Humana Inc. (HUM) stock is 58.35% over the past 12 months. The 3 year average growth rate is -9.82% and the 5 year cagr is -2.03%. Total return includes dividends reinvested.
The closing share price for Humana Inc. (HUM) stock was $363.18 for Tuesday, June 9, 2026, up +2.02% from the previous day.
HUM Price Chart
HUM Key Metrics
See All MetricsHUM Earnings Preview
Next Earnings Date
Jul 29, 2026
49 days away
EPS Estimate
6.97
Revenue Est.
$40.56B
Last Quarter Results
EPS
$10.31
vs Estimate
$10.20
Revenue
$39.65B
vs Estimate
$39.37B
HUM Analyst Ratings
Consensus Rating
Based on 24 analysts
Average Price Target
$296.63
-18.3% downside
Low
$195.00
Current
$363.18
High
$441.00
HUM Analyst Estimates
Earnings Per Share (EPS) Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $12.07 | N/A | 10 |
| Q2 2027 | N/A | $8.54 | N/A | 7 |
| Q3 2027 | N/A | $1.56 | N/A | 7 |
| Q4 2027 | N/A | $-6.35 | N/A | 14 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $15.82 | N/A | 15 |
| FY 2028 | N/A | $26.30 | N/A | 7 |
Revenue Estimates
Quarterly
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| Q1 2027 | N/A | $41.66B | N/A | 10 |
| Q2 2027 | N/A | $42.27B | N/A | 7 |
| Q3 2027 | N/A | $42.32B | N/A | 7 |
| Q4 2027 | N/A | $42.47B | N/A | 14 |
Annual
| Period | Low | Avg | High | # Analysts |
|---|---|---|---|---|
| FY 2027 | N/A | $169.69B | N/A | 15 |
| FY 2028 | N/A | $179.41B | N/A | 7 |
Source: FMP Analyst Consensus Estimates. Forward P/E calculated using average EPS estimate for the nearest fiscal year.
HUM Competitors' Key Metrics
| Stock | Market Cap | Close Price | Price Change | TTM Total Return | 5Y CAGR | 10Y CAGR |
|---|---|---|---|---|---|---|
| 1HUM | $43.60B | $363.18 | +2.02% | +58.35% | -2.03% | +7.69% |
HUM Charts
Valuation Charts
Performance Charts
CAGR Charts
Financial Statement Charts
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- Capital Expenditure
- Acquisitions
- Share Buybacks
- Stock-Based Compensation
- Total Assets
- Total Equity
- Cash & Equivalents
- Accounts Receivable
- Inventory
- PP&E
- Goodwill
- Accounts Payable
- Retained Earnings
- Total Debt
- Long-Term Debt
- Short-Term Debt
About Humana Inc.
Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
- Sector
- Healthcare
- Industry
- Medical - Healthcare Plans
- CEO
- James A. Rechtin